August 6, 2026 SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
August 6, 2026 BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering
